Nagai, Y., Ji, M. Q., Zhu, F., Xiao, Y., Tanaka, Y., Kambayashi, T., . . . Greene, M. I. (2019). PRMT5 Associates With the FOXP3 Homomer and When Disabled Enhances Targeted p185(erbB2/neu) Tumor Immunotherapy. Front Immunol.
Citação norma ChicagoNagai, Yasuhiro, et al. "PRMT5 Associates With the FOXP3 Homomer and When Disabled Enhances Targeted P185(erbB2/neu) Tumor Immunotherapy." Front Immunol 2019.
Citação norma MLANagai, Yasuhiro, et al. "PRMT5 Associates With the FOXP3 Homomer and When Disabled Enhances Targeted P185(erbB2/neu) Tumor Immunotherapy." Front Immunol 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.